Renaissance Technologies LLC increased its stake in shares of VanEck Pharmaceutical ETF (NASDAQ:PPH – Free Report) by 85.0% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 25,900 shares of the company’s stock after acquiring an additional 11,902 shares during the period. Renaissance Technologies LLC’s holdings in VanEck Pharmaceutical ETF were worth $2,369,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors have also made changes to their positions in PPH. Optimum Investment Advisors acquired a new stake in VanEck Pharmaceutical ETF in the 2nd quarter valued at approximately $27,000. GPS Wealth Strategies Group LLC bought a new stake in shares of VanEck Pharmaceutical ETF in the second quarter worth $42,000. CWM LLC acquired a new position in VanEck Pharmaceutical ETF during the second quarter worth $55,000. International Assets Investment Management LLC bought a new position in VanEck Pharmaceutical ETF in the second quarter valued at $86,000. Finally, Comerica Bank increased its stake in VanEck Pharmaceutical ETF by 39.4% in the 1st quarter. Comerica Bank now owns 1,337 shares of the company’s stock valued at $121,000 after buying an additional 378 shares during the last quarter.
VanEck Pharmaceutical ETF Price Performance
VanEck Pharmaceutical ETF stock opened at $94.54 on Wednesday. The company has a market cap of $717.56 million, a price-to-earnings ratio of 21.04 and a beta of 0.72. The firm has a 50-day moving average of $95.91 and a 200-day moving average of $91.99. VanEck Pharmaceutical ETF has a one year low of $74.05 and a one year high of $99.51.
VanEck Pharmaceutical ETF Profile
The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.
Featured Articles
- Five stocks we like better than VanEck Pharmaceutical ETF
- What is a Low P/E Ratio and What Does it Tell Investors?
- Why Lennar Stock Could Be the Best Play in the Housing Market
- What is a Stock Market Index and How Do You Use Them?
- 2 Energy Stocks Fueling the AI Datacenter Boom
- Golden Cross Stocks: Pattern, Examples and Charts
- Will Marinus Pharmaceuticals Be the Next Big Winner in Biotech?
Want to see what other hedge funds are holding PPH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for VanEck Pharmaceutical ETF (NASDAQ:PPH – Free Report).
Receive News & Ratings for VanEck Pharmaceutical ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VanEck Pharmaceutical ETF and related companies with MarketBeat.com's FREE daily email newsletter.
